Raloxifene Hydrochloride
Showing 1 - 25 of 1,843
Rheumatoid Arthritis Trial (Raloxifene HCl, Placebo Oral Tablet)
Completed
- Rheumatoid Arthritis
- Raloxifene hydrochloride
- Placebo Oral Tablet
- (no location specified)
Dec 1, 2021
Malignant Tumor, Diarrhea Trial in Guangzhou (Xiao Chai Hu Tang (XCHT), Raloxifene, FOLFIRI regimen)
Recruiting
- Malignant Tumor
- Diarrhea
- Xiao Chai Hu Tang (XCHT)
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Chinese Medicine
Aug 11, 2022
Xiao Chai Hu Tang, Irinotecan-induced Diarrhea Trial in Guangzhou (Xiao Chai Hu Tang (XCHT), Placebo, FOLFIRI/mXELIRI regimen)
Not yet recruiting
- Xiao Chai Hu Tang
- Irinotecan-induced Diarrhea
- Xiao Chai Hu Tang (XCHT)
- +3 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Traditional Chinese Medicine
Sep 24, 2023
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Melbourne (Raloxifene Hydrochloride, Placebo)
Unknown status
- Schizophrenia
- +2 more
- Raloxifene Hydrochloride
- Placebo
-
Melbourne, Victoria, AustraliaAlfred Hospital
Jan 6, 2020
Postemenopusal Women With Osteopenia Trial in Seoul (Raloxifene plus cholecalciferol, Cholecalciferol)
Recruiting
- Postemenopusal Women With Osteopenia
- Raloxifene plus cholecalciferol
- Cholecalciferol
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
May 22, 2022
Schizophrenia, Schizoaffective Disorder Trial in Melbourne (Raloxifene HCl, Placebo)
Completed
- Schizophrenia
- Schizoaffective Disorder
- Raloxifene hydrochloride
- Placebo
-
Melbourne, Victoria, AustraliaMonash Alfred Psychiatry Research Centre
Jan 6, 2020
Schizophrenia Trial in Shanghai (Raloxifene Hydrochloride, Placebo)
Completed
- Schizophrenia
- Raloxifene Hydrochloride
- Placebo
-
Shanghai, Minhang, ChinaCHINA
Sep 4, 2019
Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial (Bicalutamide, Laboratory Biomarker Analysis,
Withdrawn
- Stage I Prostate Adenocarcinoma
- Stage II Prostate Adenocarcinoma
- Bicalutamide
- +3 more
- (no location specified)
Jan 17, 2019
Rates of Esophageal Cancer in Women Taking Medications for
Replication of HORIZON Pivotal Fracture Trial in Healthcare
Completed
- Osteoporosis
- Raloxifene
- Zoledronic Acid
-
Boston, MassachusettsBrigham And Women's Hospital
Apr 30, 2021
(PASS) in the European Union (EU)
Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)
Recruiting
- Diabetic Peripheral Neuropathic Pain
- HSK16149 20mg BID
-
Luoyang, Henan, ChinaThe First Affiliated Hospital of Henan University of Science and
Nov 2, 2023
Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)
Not yet recruiting
- Laparoscopy
- Anesthesia, Intravenous
-
Guangzhou, Guangdong, China
- +11 more
Oct 15, 2023
Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)
Active, not recruiting
- Adult Solid Neoplasm
- Erlotinib Hydrochloride
- Irinotecan Hydrochloride
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin
Not yet recruiting
- Pain
- Insomnia
- Compound ibuprofen polyrelease tablets
- reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Feb 6, 2023
Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)
Not yet recruiting
- Breast Cancer
- Mitoxantrone hydrochloride liposome
- Capecitabine
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023
Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Propranolol
- Propranolol hydrochloride
- +2 more
- (no location specified)
Jul 31, 2023
Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)
Not yet recruiting
- Platinum-resistant Ovarian Cancer
- Oral Topotecan Combined With Anlotinib
-
Shanghai, ChinaXinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023
Associated With Cardiomyopathy and Heart Failure After Cancer
Recruiting
- Hodgkin Lymphoma in Remission
- +6 more
- Assessment of Therapy Complications
- +3 more
-
Birmingham, Alabama
- +78 more
Jan 11, 2023
Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)
Not yet recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablets
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Nov 9, 2023
Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in
Active, not recruiting
- Pancreatic Acinar Cell Carcinoma
- +8 more
- 3-Dimensional Conformal Radiation Therapy
- +8 more
-
Mobile, Alabama
- +697 more
Nov 16, 2022
Nausea and Vomiting Trial in Xi'an (Palonosetron HCl capsules)
Recruiting
- Nausea and Vomiting
- Palonosetron hydrochloride capsules
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital, the Air Force Medical University
Jan 18, 2023